| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 09/14/2006 | CA2599783A1 Use of an antagonist of epac for treating human cardiac hypertrophy |
| 09/14/2006 | CA2598861A1 Organic compounds |
| 09/13/2006 | EP1700921A2 Regulation of a human asparagine-hydroxylase |
| 09/13/2006 | EP1700606A1 Therapies for chronic renal failure using one or more integrin antagonists |
| 09/13/2006 | EP1699796A1 Azabicyclic heterocycles as cannabinoid receptor modulators |
| 09/13/2006 | EP1699793A1 4-amino-7,8-dihydropteridines, pharmaceutical compositions containing them and their use for the treatment of diseases which are caused by an increased nitric oxide level |
| 09/13/2006 | EP1699762A1 5-amino-4-hydroxy-7-(1h-indolmethyl)-8-methylnonamide derivatives as renin inhibitors for the treatment of hypertension |
| 09/13/2006 | EP1699760A2 Anti-hypercholesterolemic compounds |
| 09/13/2006 | EP1699759A1 Diphenylazetidinone derivates possessing cholesterol absorption inhibitory activity |
| 09/13/2006 | EP1699758A1 Diphenylazetidinone derivates processing cholesterol absorption inhibitory activity |
| 09/13/2006 | EP1699527A1 High-density lipoprotein coated medical devices |
| 09/13/2006 | EP1699495A2 Conjugates of angiotensin ii and an imaging moiety |
| 09/13/2006 | EP1699467A1 Aminoglycoside antibiotics for use as vap-1/ssao inhibitors |
| 09/13/2006 | EP1699448A2 Methods of administering 3,3,14,14 tetramethyl hexadecane 1,16 dioic acid |
| 09/13/2006 | EP1699436A2 Enoximone formulations and their use in the treatment of cardiac hypertrophy and heart failure |
| 09/13/2006 | EP1626726B1 Use of lornoxicam or lornoxicam analogue compounds |
| 09/13/2006 | EP1532145B1 Pyrazole compositions useful as inhibitors of gsk-3 |
| 09/13/2006 | EP1513942B1 Galactosyl isomalt, method for production and use thereof |
| 09/13/2006 | EP1497274B1 Terphenyl derivatives, preparation thereof, compositions containing same |
| 09/13/2006 | EP1487424B1 4-(4-methylpiperazin-1-ylmethyl)-n-(4-methyl-3(4-pyridin-3-yl)pyrimidin-2-yl-amino)phenyl)-benzamide for treating ang ii-mediated diseases |
| 09/13/2006 | EP1483257B1 Quinazoline compounds useful in therapy |
| 09/13/2006 | EP1442050B1 Linear basic compounds having nk-2 antagonist activity and formulations thereof |
| 09/13/2006 | EP1412364B1 Platelet adp receptor inhibitors |
| 09/13/2006 | EP1389206B1 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases |
| 09/13/2006 | EP1363944B1 High-affinity antagonists of elr-cxc chemokines |
| 09/13/2006 | EP1339840B1 Schizophrenia-related voltage-gated ion channel gene and protein |
| 09/13/2006 | EP1335918B1 Novel compounds |
| 09/13/2006 | EP1282643B1 Anti-inflammatory compounds and uses thereof |
| 09/13/2006 | EP1244621B1 Nitrile derivatives as cathepsin k inhibitors |
| 09/13/2006 | EP1237888B1 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
| 09/13/2006 | EP1230215B1 Pyrrole derivatives as phosphodiesterase vii inhibitors |
| 09/13/2006 | EP1224288B1 Processed human chemokine phc-1 |
| 09/13/2006 | EP1218358B1 Therapeutic quinazoline compounds |
| 09/13/2006 | EP1201236B1 Use of 2-amino-2-(2-(4-octylphenyl)ethyl)propane-1,3-diol for preventing or treating viral myocarditis |
| 09/13/2006 | EP1082319B1 Benzocarbazole and indenoindole derived estrogenic agents |
| 09/13/2006 | CN1833031A Casein hydrolyzate, process for producing the same and use thereof |
| 09/13/2006 | CN1832965A Endothelial cell specific antibodies and uses thereof |
| 09/13/2006 | CN1832958A Biologically non-degradable peptide, angiotensin converting enzyme inhibitor, drug and functional food |
| 09/13/2006 | CN1832934A Benzoxazepine-based compound |
| 09/13/2006 | CN1832763A Plasmid encoding fibroblast growth factor for the treatment of hypercholesterolemia or diabetes associated angiogenic defects |
| 09/13/2006 | CN1832728A Process for producing drug ultramicroparticle and apparatus therefor |
| 09/13/2006 | CN1831119A Hematopoietic stem cells and methods of treatment of neovascular eye diseases therewith |
| 09/13/2006 | CN1831015A Process for extracting fructus ligustri lucidi and Radixa stragali polysaccharide, the products and application thereof |
| 09/13/2006 | CN1830998A Total extractives of steroid saponin, prepn. method and application thereof |
| 09/13/2006 | CN1830981A Emulsum injection for treating cerebrovascular diseases, and its prepn. art |
| 09/13/2006 | CN1830978A Pyrazolo [4,3c]-quinolin-3-one compound, prepn. method and use thereof |
| 09/13/2006 | CN1830973A 9-anthrone lactone compounds, preparing method and use thereof |
| 09/13/2006 | CN1830476A Nanometer dragon's blood capsule and its preparation method |
| 09/13/2006 | CN1830465A Clary injection and its preparation method |
| 09/13/2006 | CN1830461A Safflower injection and its preparation method |
| 09/13/2006 | CN1830460A Xuesaitong (thrombus clearout) chewing tablet and its preparation method |
| 09/13/2006 | CN1830454A Application of hydrochloric acid in preparation of medicine for treating high blood pressure |
| 09/13/2006 | CN1830451A Preparation method of erigeron breviscapus glucese injection |
| 09/13/2006 | CN1830438A Preparation method of vitamin C freeze dried powder injection |
| 09/13/2006 | CN1830436A Vein administration ginkgolactone B powder injection and its preparation method |
| 09/13/2006 | CN1830434A Preparation method of troxerutin injection |
| 09/13/2006 | CN1830433A Preparation method of tanshinone IIA sodium sulphonate small volume injection |
| 09/13/2006 | CN1830428A Sodium ferulate injection and its preparation method |
| 09/13/2006 | CN1830427A Preparation method of sodium ferulate freeze dried powder injection |
| 09/13/2006 | CN1830423A Preparation method of garlicin injection |
| 09/13/2006 | CN1830297A Health-care vermicellic with codonopsis pilosula |
| 09/13/2006 | CN1274715C Memno peptides, a process for their preparation and their use |
| 09/13/2006 | CN1274713C Inhibitors of kallikrein |
| 09/13/2006 | CN1274690C Tricyclic and heterocyclic derivative compounds and drugs containing these compounds as active ingredient |
| 09/13/2006 | CN1274684C Bee glue flavone extract preparation method, pharmaceutical preparation and its new medical uses |
| 09/13/2006 | CN1274677C Method for preparing rilrnenidine |
| 09/13/2006 | CN1274676C Quinoline and quinazoline derivatives |
| 09/13/2006 | CN1274675C Novel cyclobutene diketone compound and its producing process, and pharmaceutical composition containing the same compound |
| 09/13/2006 | CN1274670C Diaminopropionic acid derivatives |
| 09/13/2006 | CN1274668C Salts of nateglinide |
| 09/13/2006 | CN1274365C Medicinal compositions for angiogenic therapy |
| 09/13/2006 | CN1274337C Scorpion venom cral liquor |
| 09/13/2006 | CN1274335C Medicine for treating piles and its preparing process |
| 09/13/2006 | CN1274332C Medication formulation for premonitory apoplexy and its preparation method |
| 09/13/2006 | CN1274322C Application of injection containing radix ginseng |
| 09/13/2006 | CN1274321C Astragalus injection Chinese medicinal preparation and its preparation method |
| 09/13/2006 | CN1274320C Notoginseng ginkgo health care food and its preparation method |
| 09/13/2006 | CN1274311C Application and formulation of dammarane type gen-seng low valence alcohol derivative |
| 09/12/2006 | US7105695 Anticarcinogenic agents formed by phosphorylation |
| 09/12/2006 | US7105682 Substituted amine derivatives and methods of use |
| 09/12/2006 | US7105673 Cardioprotective phosphonates and malonates |
| 09/12/2006 | US7105668 Methods and compositions utilizing quinazolinones |
| 09/12/2006 | US7105665 Compound for treatment of diarrhea, nervous system disorders such as Alzheimers and asthma in mammals |
| 09/12/2006 | US7105641 Immunoglobulin for binding monocyte chemoattractant protein-1(MCP-1) and preventing and/or treating atherosclerosis and cancer ; antitumor agents |
| 09/12/2006 | US7105572 Cardiovascular disorders |
| 09/12/2006 | US7105567 Such as N-benzyl-N'-(2,6-dimethylphenyl)-N-(4-octylphenyl)urea for treating autoimmune diseases, sepsis, adult respiratory distress syndrome, chronic obstructive pulmonary disease, allergies/asthma, atherosclerosis, and brain disorders |
| 09/12/2006 | US7105559 Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade |
| 09/12/2006 | US7105556 Conformationally constrained analogs useful as antidiabetic and antiobesity agents and method |
| 09/12/2006 | US7105552 Treatment of inflammation, inflammatory and immunological diseases, insulin resistance, hyperlipidemia, coronary artery disease, cancer and multiple sclerosis. |
| 09/12/2006 | US7105549 Aryl substituted pyridines and the use thereof |
| 09/12/2006 | US7105535 Such as n-{4-[4-(1,3-benzoxazol-2-yl)pyrazol-3-yl]phenyl}-n'-methyl urea; synthesis; cancer, cell proliferative disorders, viral infections, autoimmune diseases, neurodegenerative disorders |
| 09/12/2006 | US7105534 Imidazo[1,2-α]pyridine ether compounds as ion channel modulators |
| 09/12/2006 | US7105532 Pyrazolo[3,4-c]pyridines as gsk-3 inhibitors |
| 09/12/2006 | US7105530 Pyrimidineamines as angiogenesis modulators |
| 09/12/2006 | US7105529 A novel compound for treating alopecia induced by cancer chemotherapy or radiotherapy |
| 09/12/2006 | US7105526 Benzimidazole derivatives |
| 09/12/2006 | US7105523 Carbamate-substituted pyrazolopyridine-derivatives |
| 09/12/2006 | US7105520 Alpha 4 integrin antagonists |
| 09/12/2006 | US7105519 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 09/12/2006 | US7105508 Integrin receptors antagonists |